Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Pra Health Sciences Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.
We show how PRAH stock compares to 2,000+ US-based stocks, and to peers in the Commercial Services sector and Miscellaneous Commercial Services industry.
Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.
PRA Health Sciences, Inc. engages in the provision of outsourced clinical development services to the biotechnology and pharmaceutical industries. It operates through Clinical Research and Data Solutions segment. The Clinical Research segment serves biopharmaceutical clients and offers outsourced clinical research and clinical trial related services. The Data Solutions segment involves in data and analytics; technology solutions and real-world insights; and services primarily to the company's life science clients. The company was founded in 1976 and is headquartered in Raleigh, NC.
Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.
Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.
Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)
Stocks with higher market capitalization often have lower risk. (↑↓)
Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)
Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)
Style risk factors often include measures of profitability and payout levels.
Companies with higher earnings generally provide lower risk. (↑↓)
Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)